Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study
Open Access
- 25 September 2007
- journal article
- research article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 97 (8), 1028-1034
- https://doi.org/10.1038/sj.bjc.6603990
Abstract
5-Fluorouracil (5-FU)-based chemotherapy is frequently associated with diarrhoea. We compared two 5-FU-based regimens and the effect of Lactobacillus and fibre supplementation on treatment tolerability. Patients diagnosed with colorectal cancer (n=150) were randomly allocated to receive monthly 5-FU and leucovorin bolus injections (the Mayo regimen) or a bimonthly 5-FU bolus plus continuous infusion (the simplified de Gramont regimen) for 24 weeks as postoperative adjuvant therapy. On the basis of random allocation, the study participants did or did not receive Lactobacillus rhamnosus GG supplementation (1–2 × 1010 per day) and fibre (11 g guar gum per day) during chemotherapy. Patients who received Lactobacillus had less grade 3 or 4 diarrhoea (22 vs 37%, P=0.027), reported less abdominal discomfort, needed less hospital care and had fewer chemotherapy dose reductions due to bowel toxicity. No Lactobacillus-related toxicity was detected. Guar gum supplementation had no influence on chemotherapy tolerability. The simplified de Gramont regimen was associated with fewer grade 3 or 4 adverse effects than the Mayo regimen (45 vs 89%), and with less diarrhoea. We conclude that Lactobacillus GG supplementation is well tolerated and may reduce the frequency of severe diarrhoea and abdominal discomfort related to 5-FU-based chemotherapy.Keywords
This publication has 47 references indexed in Scilit:
- Soluble Proteins Produced by Probiotic Bacteria Regulate Intestinal Epithelial Cell Survival and GrowthGastroenterology, 2007
- Randomized Phase III Study of High-Dose Fluorouracil Given As a Weekly 24-Hour Infusion With or Without Leucovorin Versus Bolus Fluorouracil Plus Leucovorin in Advanced Colorectal Cancer: European Organization of Research and Treatment of Cancer Gastrointestinal Group Study 40952Journal of Clinical Oncology, 2003
- Abstracts ESPGHAN 36th Annual Meeting Prague, Czech Republic, June 4–7, 2003Journal of Pediatric Gastroenterology and Nutrition, 2003
- Randomized adjuvant study comparing two schemes of 5-fluorouracil and leucovorin in stage B2 and C colon adenocarcinoma: Study design and preliminary safety resultsSeminars in Oncology, 2001
- A United Kingdom Coordinating Committee on cancer research study of adjuvant chemotherapy for colorectal cancer: Preliminary resultsSeminars in Oncology, 2001
- Global cancer statisticsCA: A Cancer Journal for Clinicians, 1999
- Reduction in Diarrhea Incidence by Soluble Fiber in Patients Receiving Total or Supplemental Enteral NutritionJournal of Parenteral and Enteral Nutrition, 1994
- Externalized Groshong Catheters and Hickman Ports for Central Venous Access in Gynecologic Oncology PatientsGynecologic Oncology, 1993
- Effect of a Liquid Diet With and Without Soluble Fiber Supplementation on Intestinal Transit and Cholecystokinin Release in VolunteersJournal of Parenteral and Enteral Nutrition, 1993
- Classical external indwelling central venous catheter versus totally implanted venous access systems for chemotherapy administration: a randomized trial in 100 patients with solid tumorsEuropean Journal of Cancer and Clinical Oncology, 1989